Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect

Computer Methods and Programs in Biomedicine

Volumn 112, Issue 1, 2013, Pages 58-68

  Podduturi, Vishwa Priya ^a,b   Magaña, Isidro B ^b   O'Neal, D Patrick ^a,b   Derosa, Pedro A ^a,b,c  

^a LOUISIANA TECH UNIVERSITY   (United States)

^b Louisiana Tech University   (United States)

^c GRAMBLING STATE UNIVERSITY   (United States)

Author keywords

Drug delivery; Enhanced permeability and retention effect; EPR; Extravasation; Nanoparticle; Tumor tissue

Indexed keywords

CONTROLLABLE PARAMETERS; ENHANCED PERMEABILITY AND RETENTION EFFECT; EXTRAVASATION; INTERSTITIAL FLUID PRESSURES; NANOPARTICLE CONCENTRATIONS; PRESSURE-DRIVEN FLOWS; SUB-MICRON PARTICLES; TUMOR TISSUES;

BLOOD PRESSURE; BLOOD VESSELS; DRUG DELIVERY; PARAMAGNETIC RESONANCE; PORE SIZE; TUMORS;

NANOPARTICLES;

NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL; CAPILLARY; DRUG DELIVERY SYSTEM; EXTRAVASATION; HEAD AND NECK CARCINOMA; METASTATIC MELANOMA; MOTION; MOUSE; NEOPLASM; NONHUMAN; PARTICLE SIZE; PERMEABILITY; PRESSURE; PRESSURE GRADIENT; RECTUM CARCINOMA; SIMULATION; TEMPERATURE; TISSUE PRESSURE; TUMOR VASCULARIZATION;

DRUG DELIVERY; ENHANCED PERMEABILITY AND RETENTION EFFECT; EPR; EXTRAVASATION; NANOPARTICLE; TUMOR TISSUE;

BIOLOGICAL TRANSPORT, ACTIVE; BLOOD PRESSURE; CAPILLARIES; COMPUTER SIMULATION; DIFFUSION; DRUG DELIVERY SYSTEMS; EXTRACELLULAR FLUID; HUMANS; MODELS, BIOLOGICAL; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; PRESSURE;

EID: 84883818136     PISSN: 01692607     EISSN: 18727565     Source Type: Journal    
DOI: 10.1016/j.cmpb.2013.06.011     Document Type: Article

References (46)

1. Jang S.H., et al. Drug delivery and transport to solid tumors. Pharmaceutical Research 2003, 20:1337-1350.
2. F. Lyon, International Agency for Research on Cancer, 2010, Available at: http://globocan.iarc.fr/.
3. Bray F., et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International Journal of Cancer 2012, 132:1133-1145.
4. J. Ferlay et al., GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 (online).
5. Cancer Facts & Figures 2012, American Cancer Society.
6. Cancer Treatment and Survivorship Facts & Figures 2012-2013, American Cancer Society.
7. Howlader N., et al. SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations) 2010, National Cancer Institute.
8. Chang, et al. Application of the network model for studying the delivery of colloidal drugs. Colloid & Polymer Science 2011, 289:14.
9. Xue H., et al. Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. Journal of Parenteral and Enteral Nutrition 2011, 35(January):74-90.
10. Soltani M., Chen P. Numerical modeling of fluid flow in solid tumors. PLoS ONE 2011, 6:7.
11. Livingston R.B., Esteva F.J. Chemotherapy and herceptin for HER-2+ metastatic breast cancer: the best drug?. The Oncologist 2001, 6(August):315-316.
12. Jain R.K. Transport of molecules in the tumor interstitium: a review. Cancer Research 1987, 47(June):3039-3051.
13. Jain R.K. Transport of molecules across tumor vasculature. Cancer and Metastasis Reviews 1987, 6:559-593.
14. Hobbs S.K., et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:4607-4612.
15. Campbell R.B. Tumor physiology and delivery of nanopharmaceuticals. Anti-Cancer Agents in Medicinal Chemistry 2006, 6:503-512.
16. Monsky W.L., et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Research 1999, 59(August):4129-4135.
17. K. Ishida, O. Fau, Maruyama et al., Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice, 19991230 DCOM-19991230.
18. Stern S.T., et al. Translational considerations for cancer nanomedicine. Journal of Controlled Release 2010, 146(September):164-174.
19. Peer D., et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology 2007, 2:10.
20. Kim B.Y.S., et al. Nanomedicine. New England Journal of Medicine 2010, 363:2434-2443.
21. Li J.-L., Gu M. Gold-nanoparticle-enhanced cancer photothermal therapy. IEEE Journal of Selected Topics in Quantum Electronics 2010, 16:989-996.
22. Michalak G.J., et al. Murine photoplethysmography for in vivo estimation of vascular gold nanoshell concentration. Journal of Biomedical Optics 2010, 15:047007.
23. Michalak G.J., et al. Feasibility of using a two-wavelength photometer to estimate the concentration of circulating near-infrared extinguishing nanoparticles. Journal of Biomedical Nanotechnology 2010, 6:73-81.
24. Truskey G.A. Transport Phenomena in Biological Systems 2004, Prentice Hall, Upper Saddle River, New Jersey, USA. 2nd ed.
25. Al-Olama M., et al. The peptide AF-16 decreases high interstitial fluid pressure in solid tumors. Acta Oncologica 2011, 50:1098-1104.
26. Jain R.K., Baxter L.T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Research 1988, 48(December):7022-7032.
27. Jain R.K., et al. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Research 2007, 67:7.
28. R.J. Chapman, S.J. Fau, Shipley et al., Multiscale modeling of fluid transport in tumors, 20081013 DCOM-20081218.
29. J. Scallan et al., Capillary Fluid Exchange: Regulation, Functions, and Pathology, 2010, Available: http://www.ncbi.nlm.nih.gov/books/NBK53447/.
30. Xiaoxiao L., et al. Mass transport in solid tumors (I)-fluid dynamics. Applied Mathematics and Mechanics 1998, 19:1025-1032.
31. Frieboes H.B., et al. An integrated computational/experimental model of tumor invasion. Cancer Research 2006, 66(February):1597-1604.
32. Goodman T.T., et al. Spatio-temporal modeling of nanoparticle delivery to multicellular tumor spheroids. Biotechnolgy and Bioengineering 2008, 101(October):388-399.
33. Stylianopoulos T., et al. Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation. Biophysical Journal 2010, 99:3119-3128.
34. Frieboes H.B., et al. A computational model for predicting nanoparticle accumulation in tumor vasculature. PLoS ONE 2013, 8:e56876.
35. Mishra S., et al. Mathematical modeling of chemotherapy strategies in vascular tumor growth using nanoparticles. Applied Mathematics and Computation 2007, 189:1246-1254.
36. van de Ven A.L., et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. Journal of Controlled Release 2012, 158:148-155.
37. Mathworks, MATLAB, R2011b ed., 2011.
38. COMSOL, COMSOL Multiphysics, 4.0a ed., 2010.
39. Kiselev M.A., et al. Size of a human serum albumin molecule in solution. Biofizika 2001, 46:423-427.
40. Kong G., et al. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Research 2000, 60:6.
41. Milic i.A.F., et al. Transcytosis of albumin in capillary endothelium. Journal of Cell Biology 1988, 105:10.
42. Simionescu M.F., Palade G.E. Morphometric data on the endothelium of blood capillaries. Journal of Cell Biology 1974, 60:25.
43. Staub N.C., Schultz E.L. Pulmonary capillary length in dog, cat and rabbit. Respiration Physiology 1968, 5:9.
44. Hashizume H., et al. Openings between defective endothelial cells explain tumor vessel leakiness. American Journal of Pathology 2006, 156:17.
45. Kwon G.S. Polymeric micelles for delivery of poorly water-soluble compounds. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 20:20.
46. Zolnik B.S., Sadrieh N. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. Advanced Drug Delivery Reviews 2009, 61:422-427.